Improving the Quality of Self-Monitoring Blood Glucose Measurement: A Study in Reducing Calibration Errors

2006 ◽  
Vol 8 (3) ◽  
pp. 347-357 ◽  
Author(s):  
John M. Baum ◽  
Nanette M. Monhaut ◽  
Donald R. Parker ◽  
Christopher P. Price
2017 ◽  
Vol 11 (4) ◽  
pp. 724-735 ◽  
Author(s):  
Martina Vettoretti ◽  
Andrea Facchinetti ◽  
Giovanni Sparacino ◽  
Claudio Cobelli

Background: A reliable model of the probability density function (PDF) of self-monitoring of blood glucose (SMBG) measurement error would be important for several applications in diabetes, like testing in silico insulin therapies. In the literature, the PDF of SMBG error is usually described by a Gaussian function, whose symmetry and simplicity are unable to properly describe the variability of experimental data. Here, we propose a new methodology to derive more realistic models of SMBG error PDF. Methods: The blood glucose range is divided into zones where error (absolute or relative) presents a constant standard deviation (SD). In each zone, a suitable PDF model is fitted by maximum-likelihood to experimental data. Model validation is performed by goodness-of-fit tests. The method is tested on two databases collected by the One Touch Ultra 2 (OTU2; Lifescan Inc, Milpitas, CA) and the Bayer Contour Next USB (BCN; Bayer HealthCare LLC, Diabetes Care, Whippany, NJ). In both cases, skew-normal and exponential models are used to describe the distribution of errors and outliers, respectively. Results: Two zones were identified: zone 1 with constant SD absolute error; zone 2 with constant SD relative error. Goodness-of-fit tests confirmed that identified PDF models are valid and superior to Gaussian models used so far in the literature. Conclusions: The proposed methodology allows to derive realistic models of SMBG error PDF. These models can be used in several investigations of present interest in the scientific community, for example, to perform in silico clinical trials to compare SMBG-based with nonadjunctive CGM-based insulin treatments.


2017 ◽  
Vol 6 (3) ◽  
pp. 919-923
Author(s):  
Hassan Almarshad

In previous studies, the accuracy of glucose measurements were found with significant variations in different self-monitoring devices. This study suggests Hemoglobin a1c (Hba1c) to be used as as an indicator for the accuracy of blood-glucose monitoring devices. In this study, the association between the readings of glycohematoglobin HbA1C and the hyperglycemic readings of thirty hyperglycemic patients is used as an indicator of the accuracy of three types of glucometer devices. The association between hyperglycemic readings and the percentage of HbA1C for the same patients was investigated. The results showed significant association between levels of blood glucose and the percentage of HbA1C in three devices with statistically significant ( p < 0.05). Such relationship is suggested to be used as a relative accuracy of various types of blood glucose self-monitoring devices.


Author(s):  
A G Rumley

The quality of near-patient blood glucose measurement was audited in our hospitals in 1990, when a diversity of glucose meters were in use, by sending three samples of unknown (to the meter user) concentration to each user and collecting and analysing the results produced. The overall performance was unsatisfactory with a mean coefficient of variation (CV) of 23·5%. A scheme involving training, quality control and external quality assurance was introduced in 1993 based on the Bayer Glucometer II meter. This meter was used exclusively throughout our hospitals. Data from the quality assurance scheme showed that the overall CV fell initially to 14–16% and then settled at about 10–12% for the following 2 years. Unacceptable results (those more than two standard deviations from the mean) were 8–12% of the total. A new meter was introduced in 1995 (the Bayer Glucometer 4) which had the advantages of ‘no-wipe’ and automatic timing technology and in the subsequent year overall CV fell to 5–6% and has remained at this level. The frequency of unacceptable results fell to 5–7%. The improved precision figures encouraged us to change criteria for acceptability to mean ±15%. Using these criteria the level of unacceptable results is now 1–2%. This study shows that introducing training, quality control procedures, a quality assurance scheme and improved meter technology all backed by laboratory expertise can produce significant improvement in the quality of near patient blood glucose measurement.


1999 ◽  
Author(s):  
Airat K. Amerov ◽  
Kye Jin Jeon ◽  
Yoen-Joo Kim ◽  
Gilwon Yoon

Sign in / Sign up

Export Citation Format

Share Document